TickerFactsScreenerDevelopers

RHYTHM PHARMACEUTICALS, INC. (RYTM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $152.0K2015: $34.87M2016: $6.54M2017: $34.24M2018: $49.54M2019: $62.29M2020: $100.85M2021: $59.25M2022: $127.68M2023: $60.08M2024: $89.14M2025: $54.30M$54.30M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$54.30M-39.1%
2024$89.14M+48.4%
2023$60.08M-52.9%
2022$127.68M+115.5%
2021$59.25M-41.3%
2020$100.85M+61.9%
2019$62.29M+25.7%
2018$49.54M+44.7%
2017$34.24M+423.5%
2016$6.54M-81.2%
2015$34.87M+22840.1%
2014$152.0K—